GlassScriptPhysician profile
William V Shappley
NPI 1588733992
$16,876.95
in general payments reported to CMS, 2019-2025
50 companies · $4,017 in 2025
The $4,017 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,038 · 2020: $640 · 2021: $2,705 · 2022: $2,607 · 2023: $2,239 · 2024: $3,631 · 2025: $4,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,008 · Travel and Lodging: $1,974 · Consulting Fee: $650 · Education: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,008.46 |
| Travel and Lodging | $1,974.12 |
| Consulting Fee | $650.00 |
| Education | $254.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $4,344.21 | 2021-2025 | Urolift, Barrigel |
| Medtronic, INC. | $3,248.03 | 2021-2025 | Altaviva, Interstim |
| Boston Scientific Corporation | $1,240.46 | 2019-2024 | Solyx Sis System, Ams 700 |
| Coloplast Corp | $1,017.61 | 2021-2025 | Titan, Porges Coloplast, Speedicath |
| Accord Healthcare, INC. | $778.20 | 2024-2025 | |
| Axonics, INC. | $748.49 | 2020-2024 | Axonics, Bulkamid |
| Procept Biorobotics Corporation | $672.66 | 2019-2025 | Aquabeam Robotic System, Aquabeam System |
| Sumitomo Pharma America, INC. | $633.72 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $379.70 | 2019-2025 | Xtandi, Myrbetriq |
| Medtronic USA, INC. | $331.86 | 2019-2020 | |
| Urogen Pharma, INC. | $279.63 | 2021-2024 | Jelmyto |
| C. R. Bard, INC. & Subsidiaries | $260.56 | 2023-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Myriad Genetic Laboratories, INC. | $234.90 | 2021-2024 | Prolaris |
| Ambu INC. | $183.90 | 2023-2025 | |
| Photocure INC | $174.86 | 2021 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $150.41 | 2024 | Nanoknife |
| Srs Medical Systems, INC. | $145.64 | 2022 | |
| Verity Pharmaceuticals INC. | $129.17 | 2023-2024 | Trelstar |
| Olympus America INC. | $126.40 | 2022-2025 | Soltive |
| Abbvie INC. | $115.53 | 2022-2025 | Botox |
| Astrazeneca Pharmaceuticals LP | $112.32 | 2021 | |
| Bard Access Systems, INC. | $105.74 | 2019 | |
| Pfizer INC. | $104.33 | 2019-2025 | |
| Rochester Medical Corporation | $103.69 | 2019-2022 | |
| Intuitive Surgical, INC. | $95.46 | 2023 | Da Vinci Surgical System |
| Karl Storz Endoscopy-America | $93.57 | 2021 | |
| Dendreon Pharmaceuticals LLC | $90.78 | 2020-2023 | Provenge |
| Endo Pharmaceuticals INC. | $77.65 | 2022-2023 | Xiaflex |
| Myovant Sciences INC. | $71.78 | 2022 | |
| Sun Pharmaceutical Industries INC. | $71.76 | 2025 | |
| Clarus Therapeutics INC. | $64.75 | 2021 | |
| Laborie Medical Technologies Corp. | $64.22 | 2020-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Ferring Pharmaceuticals INC. | $59.34 | 2019-2025 | Adstiladrin |
| Agiliti Surgical, INC. | $56.90 | 2019 | |
| Tolmar, INC. | $52.11 | 2023-2025 | Eligard, Jatenzo |
| Biotissue Holdings INC. | $49.30 | 2025 | |
| Allergan, INC. | $48.17 | 2021 | |
| Urovant Sciences INC | $43.67 | 2021-2022 | |
| Blue Earth Diagnostics | $42.23 | 2019-2021 | |
| Janssen Biotech, INC. | $41.57 | 2025 | Erleada |
| Endo USA, INC. | $38.69 | 2024-2025 | Xiaflex |
| Integra Lifesciences Corporation | $24.68 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $24.22 | 2023 | Stravix |
| Davol INC. | $23.88 | 2024 | Arista Ah Flexitip |
| Travere Therapeutics, INC. | $23.35 | 2019-2021 | |
| Progenics Pharmaceuticals, INC. | $22.72 | 2025 | |
| Neotract INC. | $20.61 | 2020 | |
| Merck Sharp & Dohme LLC | $19.63 | 2020 | |
| Novartis Pharmaceuticals Corporation | $19.50 | 2025 | |
| Axogen | $14.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Shappley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.